US Patent Issued to HELMHOLTZ ZENTRUM MUENCHEN-DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT (GMBH) on March 24 for "microRNA inhibitors for use in treating metabolic diseases" (German Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,584,126, issued on March 24, was assigned to HELMHOLTZ ZENTRUM MUENCHEN-DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT (GMBH) (Germany).

"microRNA inhibitors for use in treating metabolic diseases" was invented by Stephan Herzig (Vaterstetten, Germany), Manuel Gil Lozano (Unterschleissheim, Germany) and Tobias Schafmeier (Neubiberg, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to composition comprising an inhibitor of miR-379 or a portion or fragment thereof and an inhibitor of miR-541 or a portion or fragment thereof, and/or an inhibitor of the target site of miR-379 or a portion or fragment thereof and ...